{"entity":{"type":"insider","cik":"0001905248","url":"/insider/0001905248","json_url":"/insider/0001905248.json","name":"Espinoza Octavio","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":11,"first":"2022-11-10","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Espinoza Octavio","source":"filing","n_filings":11,"first_seen":"2022-11-10","last_seen":"2026-08-14"}],"transactions":[{"id":9297000,"accession":"0002001011-26-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-26-000115","line_url":"/filing/0002001011-26-000115#line-1","is_derivative":false,"issuer_cik":"0001905248","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0001905248","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31641.0,"shares_display":"31,641","price_per_share":292.065,"price_display":"292.06","price_state":"stated","total_value":9241228.665,"total_display":"9,241,228.66","total_whole":"9,241,229","shares_owned_after":27696.0,"shares_owned_after_display":"27,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider"},{"id":5938970,"accession":"0002001011-26-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002001011-26-000026","line_url":"/filing/0002001011-26-000026#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3057.0,"shares_display":"3,057","price_per_share":225.0,"price_display":"225.00","price_state":"stated","total_value":687825.0,"total_display":"687,825.00","total_whole":"687,825","shares_owned_after":21010.0,"shares_owned_after_display":"21,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-13","scope":"insider"},{"id":6121802,"accession":"0002001011-26-000023","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0002001011-26-000023","line_url":"/filing/0002001011-26-000023","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13423.0,"shares_display":"13,423","price_per_share":205.82747865603815,"price_display":"205.83","price_state":"stated","total_value":2762822.246,"total_display":"2,762,822.25","total_whole":"2,762,822","shares_owned_after":21662.0,"shares_owned_after_display":"21,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider","n_lines":11},{"id":4448317,"accession":"0002001011-25-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-25-000125","line_url":"/filing/0002001011-25-000125#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1804.0,"shares_display":"1,804","price_per_share":188.31,"price_display":"188.31","price_state":"stated","total_value":339711.24,"total_display":"339,711.24","total_whole":"339,711","shares_owned_after":26186.0,"shares_owned_after_display":"26,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-12","filed_date":"2025-12-16","scope":"insider"},{"id":5181042,"accession":"0002001011-25-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002001011-25-000028","line_url":"/filing/0002001011-25-000028","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":104.06,"price_display":"104.06","price_state":"stated","total_value":156090.0,"total_display":"156,090.00","total_whole":"156,090","shares_owned_after":27432.0,"shares_owned_after_display":"27,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-09","filed_date":"2025-05-13","scope":"insider","n_lines":2},{"id":4518958,"accession":"0002001011-25-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002001011-25-000015","line_url":"/filing/0002001011-25-000015#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":115.0297,"price_display":"115.03","price_state":"stated","total_value":575148.5,"total_display":"575,148.50","total_whole":"575,149","shares_owned_after":18879.0,"shares_owned_after_display":"18,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":2296693,"accession":"0002001011-24-000107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-24-000107","line_url":"/filing/0002001011-24-000107#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2104.0,"shares_display":"2,104","price_per_share":116.3738,"price_display":"116.37","price_state":"stated","total_value":244850.4752,"total_display":"244,850.48","total_whole":"244,850","shares_owned_after":20647.0,"shares_owned_after_display":"20,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-26","scope":"insider"},{"id":2623326,"accession":"0002001011-24-000088","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002001011-24-000088","line_url":"/filing/0002001011-24-000088","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1275.0,"shares_display":"1,275","price_per_share":103.93583333333333,"price_display":"103.94","price_state":"stated","total_value":132518.1875,"total_display":"132,518.19","total_whole":"132,518","shares_owned_after":24610.0,"shares_owned_after_display":"24,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-24","scope":"insider","n_lines":3},{"id":2880061,"accession":"0002001011-24-000053","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0002001011-24-000053","line_url":"/filing/0002001011-24-000053","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5156.0,"shares_display":"5,156","price_per_share":86.66479716834756,"price_display":"86.66","price_state":"stated","total_value":446843.6942,"total_display":"446,843.69","total_whole":"446,844","shares_owned_after":23513.0,"shares_owned_after_display":"23,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":2880038,"accession":"0002001011-24-000053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002001011-24-000053","line_url":"/filing/0002001011-24-000053#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2264.0,"shares_display":"2,264","price_per_share":86.0034,"price_display":"86.00","price_state":"stated","total_value":194711.6976,"total_display":"194,711.70","total_whole":"194,712","shares_owned_after":21618.0,"shares_owned_after_display":"21,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider"},{"id":2880031,"accession":"0002001011-24-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002001011-24-000053","line_url":"/filing/0002001011-24-000053#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5873.0,"shares_display":"5,873","price_per_share":86.012,"price_display":"86.01","price_state":"stated","total_value":505148.476,"total_display":"505,148.48","total_whole":"505,148","shares_owned_after":23882.0,"shares_owned_after_display":"23,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-17","scope":"insider"},{"id":2446702,"accession":"0002001011-24-000028","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0002001011-24-000028","line_url":"/filing/0002001011-24-000028#line-5","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":140.0,"shares_display":"140","price_per_share":88.46,"price_display":"88.46","price_state":"stated","total_value":12384.4,"total_display":"12,384.40","total_whole":"12,384","shares_owned_after":29755.0,"shares_owned_after_display":"29,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-29","scope":"insider"},{"id":6472348,"accession":"0000899243-22-035519","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035519","line_url":"/filing/0000899243-22-035519#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001905248","owner_name":"Espinoza Octavio","owner_display_name":"Espinoza Octavio","owner_url":"/insider/0001905248","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1696.0,"shares_display":"1,696","price_per_share":75.6383,"price_display":"75.64","price_state":"stated","total_value":128282.5568,"total_display":"128,282.56","total_whole":"128,283","shares_owned_after":8857.0,"shares_owned_after_display":"8,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-09","filed_date":"2022-11-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Officer (Chief Financial Officer)","n_filings":11,"first_seen":"2022-11-10","last_seen":"2026-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001905248","retrieved_at":"2026-08-22T21:51:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}